XML 23 R9.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY AND REDEEMABLE NONCONTROLLING INTERESTS (UNAUDITED) - USD ($)
$ in Thousands
Total
Total Lazard Stockholders’ Equity
Common Stock
Additional Paid-In- Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss), Net of Tax
Common Stock Held By Subsidiaries
Noncontrolling Interests
Redeemable Noncontrolling Interests
Balance at the beginning (in shares) at Dec. 31, 2023     112,766,091       25,340,287    
Balance at the beginning at Dec. 31, 2023 $ 482,187 $ 423,759 $ 1,128 $ 247,204 $ 1,402,636 $ (289,950) $ (937,259) $ 58,428  
Comprehensive income (loss):                  
Net income (loss) 37,607 35,755     35,755     1,852  
Other comprehensive income (loss) - net of tax (14,045) (14,045)       (14,045)      
Amortization of share-based incentive compensation 70,198 69,773   69,773       425  
Dividend equivalents (5,527) (406)   9,441 (9,847)     (5,121)  
Common stock dividends $ (43,715) (43,715)     (43,715)        
Purchase of common stock (in shares) 564,692           564,692    
Purchase of common stock $ (22,005) (22,005)         $ (22,005)    
Delivery of common stock in connection with share-based incentive compensation and related tax expense (benefit) (in shares)             (3,656,974)    
Delivery of common stock in connection with share-based incentive compensation and related tax expense (benefit) (56,396) (57,637)   (193,080)     $ 135,443 1,241  
Business acquisitions and related equity transactions: Common stock issuable 1,235 1,235   1,235          
Distributions to noncontrolling interests, net (1,008)             (1,008)  
Balance at the end (in shares) at Mar. 31, 2024     112,766,091       22,248,005    
Balance at the end at Mar. 31, 2024 448,531 392,714 $ 1,128 134,573 1,384,829 (303,995) $ (823,821) 55,817  
Balance at the beginning at Dec. 31, 2023                 $ 87,675
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Net income                 2,617
LFI Consolidated Funds                 (1,817)
Balance at the end at Mar. 31, 2024                 88,475
Balance at the beginning (in shares) at Dec. 31, 2024     112,766,091       22,467,315    
Balance at the beginning at Dec. 31, 2024 685,154 636,240 $ 1,128 327,810 1,472,113 (326,742) $ (838,069) 48,914  
Comprehensive income (loss):                  
Net income (loss) 63,181 60,375     60,375     2,806  
Other comprehensive income (loss) - net of tax 20,000 19,976       19,976   24  
Amortization of share-based incentive compensation 77,168 74,950   74,950       2,218  
Dividend equivalents (7,466) (455)   9,421 (9,876)     (7,011)  
Common stock dividends $ (44,950) (44,950)     (44,950)        
Purchase of common stock (in shares) 773,955           773,955    
Purchase of common stock $ (36,165) (36,165)         $ (36,165)    
Delivery of common stock in connection with share-based incentive compensation and related tax expense (benefit) (in shares)             (4,664,538)    
Delivery of common stock in connection with share-based incentive compensation and related tax expense (benefit) (104,435) (102,913)   (278,381)     $ 175,468 (1,522)  
Business acquisitions and related equity transactions: Common stock issuable 1,235 1,235   1,235          
Contributions from noncontrolling interests, net 96             96  
Other (in shares)             41,969    
Other (5,265) (5,265)   (3,338)     $ (1,927)    
Balance at the end (in shares) at Mar. 31, 2025     112,766,091       18,618,701    
Balance at the end at Mar. 31, 2025 $ 648,553 $ 603,028 $ 1,128 $ 131,697 $ 1,477,662 $ (306,766) $ (700,693) $ 45,525  
Balance at the beginning at Dec. 31, 2024                 79,629
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Net income                 (1,192)
LFI Consolidated Funds                 5,374
Balance at the end at Mar. 31, 2025                 $ 83,811